A handful of vaccines, including those from Pfizer Inc and AstraZeneca, are also being tested in large studies.
Moderna had enrolled 25,296 participants out of a planned 30,000 in its late-stage study as of Wednesday.
Moderna has a vaccine supply deal in place with the U.S. for 100 million doses, and has finished advanced talks with the
European Union for the vaccine.